A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status

The clinical benefit of adding platinum to adjuvant chemotherapy for patients with triple-negative breast cancer (TNBC) has not been well investigated, although it was associated an improved response rate in neoadjuvant setting. We retrospectively analyzed the time to tumor progression (TTP) and ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ying-Wen, Hung, Chia-Yen, Lam, Hung-Bun, Chang, Yuan-Ching, Yang, Po-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Triple-Negative Breast Cancer - Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104219/
https://www.ncbi.nlm.nih.gov/pubmed/30150877
http://dx.doi.org/10.1177/1179554918794672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104219/
https://www.ncbi.nlm.nih.gov/pubmed/30150877
http://dx.doi.org/10.1177/1179554918794672

Ejemplares similares